Histamine H3 antagonists in models of obesity

被引：12

作者：

Hancock, AA ^{[1
]}

Bush, EN ^{[1
]}

Jacobson, PB ^{[1
]}

Faghih, R ^{[1
]}

Esbenshade, TA ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

来源：

INFLAMMATION RESEARCH | 2004年 / 53卷 / Suppl 1期

关键词：

Obesity; Histamine;

D O I：

10.1007/s00011-003-0322-5

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：S47 / S48

页数：2

共 7 条

[1]

BJENNING C, 2000, INT SEND HIST S, P145

[2] Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands [J].

Faghih, R ;

Dwight, W ;

Vasudevan, A ;

Dinges, J ;

Conner, SE ;

Esbenshade, TA ;

Bennani, YL ;

Hancock, AA .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (21) :3077-3079

[3] Thioperamide, a histamine H3 receptor antagonist, powerfully suppresses peptide YY-induced food intake in rats [J].

Itoh, E ;

Fujimiya, M ;

Inui, A .

BIOLOGICAL PSYCHIATRY, 1999, 45 (04) :475-481

[4] New approaches in the pharmacological treatment of obesity [J].

Leonhardt, M ;

Hrupka, B ;

Langhans, W .

EUROPEAN JOURNAL OF NUTRITION, 1999, 38 (01) :1-13

[5] Inhibition and induction of cytochrome P450 and the clinical implications [J].

Lin, JH ;

Lu, AYH .

CLINICAL PHARMACOKINETICS, 1998, 35 (05) :361-390

[6] Brain histamine and feeding behavior [J].

Morimoto, T ;

Yamamoto, Y ;

Yamatodani, A .

BEHAVIOURAL BRAIN RESEARCH, 2001, 124 (02) :145-150

[7]

YATES SL, 2000, EFFECTS NOVEL HISTAM

← 1 →